Trial Profile
Randomized Trial of Fish Oil Versus Placebo to Reduce ALT Levels in Overweight Adolescents
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Fatty liver; Non-alcoholic fatty liver disease
- Focus Adverse reactions; Therapeutic Use
- 12 Feb 2016 New trial record